Targeting myeloid leukemia stem cells. - Wikidata - awgldk - TriplyDB

Targeting myeloid leukemia stem cells.

Targeting myeloid leukemia stem cells.

http://www.wikidata.org/entity/Q37750200

about

Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem Cells Clathrin assembly protein CALM plays a critical role in KIT signaling by regulating its cellular transport from early to late endosomes in hematopoietic cells.Discovery of Power-Law Growth in the Self-Renewal of Heterogeneous Glioma Stem Cell Populations Preferential eradication of acute myelogenous leukemia stem cells by fenretinide.NK cells from an AML patient have recovered in remission and reached comparable cytolytic activity to that of a healthy monozygotic twin mediated by the single-chain triplebody SPM-2.Properties and feasibility of using cancer stem cells in clinical cancer treatment.Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells.How to improve the immunogenicity of chemotherapy and radiotherapy.Aldehyde dehydrogenases in acute myeloid leukemia.CD123 target validation and preclinical evaluation of ADCC activity of anti-CD123 antibody CSL362 in combination with NKs from AML patients in remission.Synthesis and antileukemic activities of C1-C10-modified parthenolide analogues.GPR56 contributes to the development of acute myeloid leukemia in mice.Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia Evolution of acute myelogenous leukemia stem cell properties after treatment and progression.

P2860

Q28391575-5005BE9F-B70D-41EE-9087-49483A156D85 Q34287371-FFCBC3D4-1D06-46DA-BB97-E1534EBE9C1D Q35748846-8D30BE1D-532E-4A50-8BB6-64D16F58C72A Q36747742-5AFDFEB8-54A4-4734-A554-EB0E83DAC645 Q37348420-32F168C2-5581-4BA0-8325-9C2C4F6C6104 Q37596687-4F1D12CA-29C2-44E4-A364-9D75B9BAAB84 Q37697847-0029418D-D6F2-4C46-9E66-780064500432 Q37836489-4BE32A45-A882-4156-9EBE-9741F685ADC2 Q38196948-18D1216A-580A-45CF-88A8-E4452CCAFB65 Q38748924-5DD182A0-6554-4586-9A7B-65976C922002 Q38862410-F867705F-5672-41F7-A218-8DCEEECC345F Q40808168-576BD841-4B8A-4A71-BD8B-D75888BBD44C Q41558781-5743BAF3-9771-4890-9E20-E32C769D897B Q41663784-05120751-FD81-4911-B4C7-8249D5FAFD08

P2860

Targeting myeloid leukemia stem cells.

http://www.wikidata.org/entity/Q37750200

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Targeting myeloid leukemia stem cells.

@en

Targeting myeloid leukemia stem cells.

@nl

type

label

Targeting myeloid leukemia stem cells.

@en

Targeting myeloid leukemia stem cells.

@nl

prefLabel

Targeting myeloid leukemia stem cells.

@en

Targeting myeloid leukemia stem cells.

@nl

P1433

Q37750200-104AFAB8-3B25-43D1-9493-B5250FB04612

P1476

Q37750200-FE7BF2F5-8640-4A71-BD17-248FD7608172

P2093

Q37750200-A5788EE7-863D-4BAA-92BB-1C6AFB7F9628

P2860

Q37750200-19D44889-1D2D-4B2A-BFC1-B4ED5A232C66

Q37750200-2F102CB0-CF91-4457-9542-8ACF81B8F6DE

Q37750200-36539113-5396-4E84-B2C5-BC01F41FB44B

Q37750200-52CF557A-A4BE-4073-8615-5C054FACDC87

Q37750200-667320C6-F1A4-49C1-A58E-C528EE4E86C1

Q37750200-763D102B-8FF0-4E11-9FF9-8D5DA0D04633

Q37750200-7DC1F1BA-B318-4544-9E6E-54129FC02CA8

Q37750200-A1B57D3B-DFFE-4E7C-BE21-9921F3D00DD2

Q37750200-A538DFEF-271D-4B77-AAC3-9D7901693A4F

Q37750200-AD05E98F-27F4-4C6F-B1AA-580B7232F1E1

P304

Q37750200-AF0B6F73-5DB2-440A-BC22-5ABFC198A8D9

P31

Q37750200-73EDE7DE-E7AD-40AB-9693-5AD32C5D2521

P356

Q37750200-DB0F0A44-1D9D-4710-976E-63D6CBB298E7

P407

Q37750200-92557F4D-A270-46E9-8247-5080463A78A6

P433

Q37750200-1A890116-2A13-49F3-AEF6-769BE7DDC203

P478

Q37750200-F2D2DE80-6C9E-459C-A14D-E3D9E0FB3062

P577

Q37750200-F8A80E5C-42BE-4A82-8B79-7E2178AE6F75

P5875

Q37750200-ECF1BE5E-DDBF-415B-A965-C6FBD6E9A8A2

P698

Q37750200-E26CEB14-9836-478A-A535-4EC0F2B905D9

P921

Q37750200-2E949670-C1D2-45B1-9E52-30ADB0D7E735

P356

SCITRANSLMED.3000914

P1433

Science Translational Medicine

P1476

Targeting myeloid leukemia stem cells.

@en

P2093

Craig T Jordan

http://www.w3.org/2001/XMLSchema#string

P2860

CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis

Stem cells, cancer, and cancer stem cells

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells

Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells

Implications of the expression of myeloid markers on normal and leukemic stem cells.

Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction.

Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells.

The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells.

P304

31ps21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCITRANSLMED.3000914

http://www.w3.org/2001/XMLSchema#string

P407

P433

31

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44592959

http://www.w3.org/2001/XMLSchema#string

P698

20463365

http://www.w3.org/2001/XMLSchema#string

P921